Published in Eur J Clin Microbiol Infect Dis on April 01, 1992
Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomised trial. Lancet (1999) 3.86
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ (2000) 2.97
Cross sectional retrospective study of prevalence of atopy among Italian military students with antibodies against hepatitis A virus. BMJ (1997) 2.70
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med (1994) 2.55
Association between hepatitis E virus and HIV infection in homosexual men. Lancet (1994) 2.49
Incidence and consequences of pregnancy in women with known duration of HIV infection. Italian Seroconversion Study Group. Arch Intern Med (1998) 2.38
Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat Med (1999) 2.27
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood (1999) 2.10
Chikungunya in north-eastern Italy: a summing up of the outbreak. Euro Surveill (2007) 2.07
High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS (1996) 1.92
Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy. Dig Liver Dis (2001) 1.89
An outbreak of chikungunya fever in the province of Ravenna, Italy. Euro Surveill (2007) 1.81
The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol (2000) 1.77
Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis (2001) 1.77
Cancer incidence in a cohort of human immunodeficiency virus seroconverters. HIV Italian Seroconversion Study Group. Cancer (1997) 1.73
Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis (2005) 1.69
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol (1996) 1.67
Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis. J Epidemiol Community Health (2008) 1.61
How many HIV-infected individuals may be defined as long-term nonprogressors? A report from the Italian Seroconversion Study. Italian Seroconversion Study Group (ISS) J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.57
Incidence and determinants of hepatitis C virus infection among individuals at risk of sexually transmitted diseases attending a human immunodeficiency virus type 1 testing program. Sex Transm Dis (1997) 1.57
Probable autochthonous introduced malaria cases in Italy in 2009-2011 and the risk of local vector-borne transmission. Euro Surveill (2012) 1.54
An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users. J Infect Dis (1996) 1.51
Travel-associated hepatitis A: effect of place of residence and country visited. J Public Health Med (1991) 1.51
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town. J Hepatol (2000) 1.48
Antiviral treatment for hepatitis C virus infection: effectiveness at general population level in a highly endemic area. Dig Liver Dis (2009) 1.44
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut (2004) 1.42
Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. J Med Virol (2005) 1.42
Hepatitis G virus in intramuscular and intravenous immunoglobulin products manufactured in Europe. Transfusion (1999) 1.40
AIDS in Italy. Lancet (1984) 1.38
Combining HIV and AIDS surveillance: an experience from an Italian region. Int J Epidemiol (1997) 1.38
Epidemic Kaposi's sarcoma in Italy, a country with intravenous drug abusers as the major group at risk for AIDS: report of 60 cases. AIDS (1989) 1.38
Nucleic acid amplification technology screening for HBV DNA in Italy: routine application. Report on the first HBV DNA-positive HBsAG-negative donor. Transfus Med (2005) 1.38
Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile. Ital J Gastroenterol Hepatol (1999) 1.38
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis (1997) 1.29
HIV seroprevalence among 304 female prostitutes from four Italian towns. AIDS (1989) 1.27
Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer (2003) 1.26
Increasing survival time after AIDS in Italy: the role of new combination antiretroviral therapies. Tuscany AIDS Study Group. AIDS (1999) 1.26
Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P). Vaccine (2001) 1.26
Sibship size, birth order, and atopy in 11,371 Italian young men. J Allergy Clin Immunol (1998) 1.23
Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23
Integrated epidemiological system for acute viral hepatitis in Italy (SEIEVA): description and preliminary results. Eur J Epidemiol (1986) 1.21
Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer (1999) 1.20
Investigation of an imported case of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Florence, Italy, May to June 2013. Euro Surveill (2013) 1.20
Epidemiology of hepatitis B in Italy. Ann Ist Super Sanita (1987) 1.20
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (1994) 1.20
Correlation between virus genotype and chronicity rate in acute hepatitis C. J Hepatol (1998) 1.20
Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut (2006) 1.19
West Nile virus transmission with human cases in Italy, August - September 2009. Euro Surveill (2009) 1.18
Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study. AIDS Care (1994) 1.17
Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect (2009) 1.17
Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med (1998) 1.16
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst (1999) 1.16
Direct comparison of time to AIDS and infectious disease death between HIV seroconverter injection drug users in Italy and the United States: results from the ALIVE and ISS studies. AIDS Link to Intravenous Experiences. Italian Seroconversion Study. J Acquir Immune Defic Syndr Hum Retrovirol (1999) 1.15
World Health Organization collaborative study to establish a replacement WHO international standard for hepatitis C virus RNA nucleic acid amplification technology assays. Vox Sang (2005) 1.15
Circulation of West Nile virus lineage 1 and 2 during an outbreak in Italy. Clin Microbiol Infect (2012) 1.14
ETDRS-fast: implementing psychophysical adaptive methods to standardized visual acuity measurement with ETDRS charts. Invest Ophthalmol Vis Sci (2001) 1.13
Immunosuppression, timing of human herpesvirus 8 infection, and risk of Kaposi's sarcoma among human immunodeficiency virus type 1-infected persons and transplant recipients. J Infect Dis (2000) 1.12
Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol (2001) 1.10
Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood (1999) 1.10
Severe acute respiratory syndrome. J Epidemiol Community Health (2003) 1.10
Epidemiological surveillance of West Nile neuroinvasive diseases in Italy, 2008 to 2011. Euro Surveill (2012) 1.09
Behavioural patterns and HIV infection among drug using transvestites practising prostitution in Rome. AIDS Care (1992) 1.08
Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer (1998) 1.08
MhcDRB-sequences from cynomolgus macaques (Macaca fascicularis) of different origin. Tissue Antigens (2004) 1.07
GBR12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine. Pharmacol Biochem Behav (1991) 1.07
Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol (1999) 1.07
Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: results of a national survey. AIDS Care (2006) 1.07
Risks of acute renal failure after cardiopulmonary bypass surgery in children: a retrospective 10-year case-control study. Nephrol Dial Transplant (1995) 1.04
Hepatitis B and Delta virus infection among heterosexuals, homosexuals and bisexual men. Eur J Epidemiol (1988) 1.04
Investigation of a Q-fever outbreak in northern Italy. Eur J Epidemiol (1996) 1.04
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol (1999) 1.04
Estimation of the acquired immunodeficiency syndrome incubation period in intravenous drug users: a comparison with male homosexuals. Am J Epidemiol (1992) 1.03
A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol (2001) 1.03
Increasing proportion of late testers among AIDS cases in Italy, 1996-2002. AIDS Care (2005) 1.02
Airway management in an infant with congenital centrofacial dysgenesia. Br J Anaesth (2002) 1.02
Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects. Clin Infect Dis (1996) 1.02
Acute hepatitis A in Italy: incidence, risk factors and preventive measures. J Viral Hepat (2008) 1.01
Longitudinal human immunodeficiency virus type 1 load in the italian seroconversion study: correlates and temporal trends of virus load. J Infect Dis (1999) 1.01
Temporal changes in the rate of progression to death among Italians with known date of HIV seroconversion: estimates of the population effect of treatment. Italian HIV Seroconversion Study (ISS). J Acquir Immune Defic Syndr (1999) 1.01
Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer (2005) 1.01
Screening for hepatocellular carcinoma. Dig Liver Dis (2005) 1.00
The classification of AIDS cases: concordance between two AIDS surveillance systems in Italy. Am J Public Health (1995) 1.00
Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients. J Infect (2001) 1.00
SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine. J Med Primatol (2000) 0.99